StockData
BriaCell Therapeutics Corp. logo

BriaCell Therapeutics Corp. (BCTX) stock

BCTXNasdaqPharmaceutical PreparationsFiscal year ends July 31Also trades as BCTXL, BCTXZ
Financials through Q4 FY2026, quarter ended Jul 31, 2026Last filing: 10-K on Oct 28, 2026Score 4/30
$3.51−0.08 (-2.23%)

Close on Nov 12, 2026Market cap $30.65MP/E –Yield –

Earnings

BriaCell Therapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
–
Not yet scheduled
Revenue
–
EPS
–
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of BriaCell Therapeutics's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2022ended Jul 31, 2022Oct 28, 2022during market hours–––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

BriaCell Therapeutics has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When BriaCell Therapeutics puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases BriaCell Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K

  1. THE THREE AND NINE MONTH PERIOD ENDED APRIL 30, 2026
    Update
  2. the three and nine months ended April 30, 2026
    Update
  3. Therapeutics Announces Pricing of Offering
    News
  4. Therapeutics Announces Closing of Offering
    News
  5. THE THREE AND SIX MONTH PERIOD ENDED JANUARY 31, 2026
    Update
  6. the three and six months ended January 31, 2026
    Update
  7. and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License
    News
  8. Therapeutics Announces Pricing of $30 million Public Offering
    News
  9. Therapeutics Announces Closing of US$30 million Public Offering
    News
  10. THE THREE MONTH PERIOD ENDED OCTOBER 31, 2025
    Update
  11. the three months ended October 31, 2025
    Update
  12. THE PERIOD ENDED JULY 31, 2025
    Update
  13. the Year Ended July 31, 2025
    Update
  14. Announces Proposed Effective Date of Share Consolidation
    News
  15. Therapeutics Announces Pricing of $15 million Public Offering
    News

See a number that looks wrong?